DK0539215T3 - Forøgelse af penetrationen af topisk anvendelige formuleringer - Google Patents

Forøgelse af penetrationen af topisk anvendelige formuleringer

Info

Publication number
DK0539215T3
DK0539215T3 DK92309727T DK92309727T DK0539215T3 DK 0539215 T3 DK0539215 T3 DK 0539215T3 DK 92309727 T DK92309727 T DK 92309727T DK 92309727 T DK92309727 T DK 92309727T DK 0539215 T3 DK0539215 T3 DK 0539215T3
Authority
DK
Denmark
Prior art keywords
penetration
increasing
topically applicable
vitamin
applicable formulations
Prior art date
Application number
DK92309727T
Other languages
English (en)
Inventor
Joseph Synodis
Stuart Wilensky
Original Assignee
Stafford Miller Ltd
Stafford Miller Continental Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25135484&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0539215(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stafford Miller Ltd, Stafford Miller Continental Nv filed Critical Stafford Miller Ltd
Application granted granted Critical
Publication of DK0539215T3 publication Critical patent/DK0539215T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92309727T 1991-10-23 1992-10-23 Forøgelse af penetrationen af topisk anvendelige formuleringer DK0539215T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78542691A 1991-10-23 1991-10-23

Publications (1)

Publication Number Publication Date
DK0539215T3 true DK0539215T3 (da) 1999-05-03

Family

ID=25135484

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92309727T DK0539215T3 (da) 1991-10-23 1992-10-23 Forøgelse af penetrationen af topisk anvendelige formuleringer

Country Status (11)

Country Link
US (1) US6017520A (da)
EP (1) EP0539215B1 (da)
JP (1) JP2671248B2 (da)
KR (1) KR930007445A (da)
AT (1) ATE169228T1 (da)
AU (1) AU658681B2 (da)
CA (1) CA2081269C (da)
DE (1) DE69226491T2 (da)
DK (1) DK0539215T3 (da)
ES (1) ES2119800T3 (da)
NZ (1) NZ244862A (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161004C (en) * 1993-04-20 2004-10-26 Wilfried Fischer Active ingredient patch
CA2166722A1 (en) * 1994-05-06 1995-11-16 Manoj L. Maniar Use of vitamin e tocopheryl derivatives in ophthalmic compositions
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1996020712A1 (en) * 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
EP0766960B1 (en) 1995-04-21 2003-09-17 Sekisui Kagaku Kogyo Kabushiki Kaisha External preparations for treating dermatoses
EP0907354B1 (en) * 1996-03-14 2002-05-29 Johnson & Johnson Consumer Companies, Inc. Cleansing and moisturizing surfactant compositions
US6730679B1 (en) 1996-03-22 2004-05-04 Smithkline Beecham Corporation Pharmaceutical formulations
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US20040067212A1 (en) * 1998-03-11 2004-04-08 Kabushiki Kaisha Soken Skin conditioner
KR20000000840A (ko) * 1998-06-03 2000-01-15 김영대 신규한 폴리옥시프로필렌폴리옥시에틸렌 비타민 e 및 그의제조방법
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
CZ20012926A3 (cs) * 1999-02-12 2002-02-13 The Procter & Gamble Company Kosmetické prostředky obsahující vitaminové B3 sloučeniny
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6383505B1 (en) 2000-11-09 2002-05-07 Steris Inc Fast-acting antimicrobial lotion with enhanced efficacy
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
CA2484637A1 (en) * 2002-05-06 2003-11-20 Elan Pharma International Ltd. Nanoparticulate nystatin formulations
AU2003240824B9 (en) * 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
JP2004123633A (ja) * 2002-10-03 2004-04-22 Medorekkusu:Kk 外用製剤
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
US20040191279A1 (en) * 2003-03-28 2004-09-30 Klofta Thomas James Tacky skin care compositions and articles having tacky skin care compositions disposed thereon
CN101090702B (zh) * 2003-10-03 2011-06-08 宝洁公司 局部用组合物
US9314431B2 (en) * 2005-02-14 2016-04-19 Transdermal Corp Solubilized benzoyl small molecule
US9308268B2 (en) * 2005-02-14 2016-04-12 Transdermal Corp Solubilized benzoyl peroxyde acne
US20090304820A1 (en) * 2008-06-05 2009-12-10 Pankaj Modi Solubilized benzoyl peroxide topical drug formulation for the treatment of acne
US7563464B1 (en) * 2005-04-22 2009-07-21 Bruce Eric Hudkins Treatment of mucosal membranes utilizing phytoestrogen
WO2008037809A1 (en) * 2006-09-29 2008-04-03 Abbott Gmbh & Co. Kg Transmucosal administration of fibrate compounds and delivery system therefor
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
WO2018122344A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
IN142640B (da) * 1975-01-17 1977-08-06 Johnson & Johnson
JPS5579318A (en) * 1978-12-07 1980-06-14 Taisho Pharmaceut Co Ltd Poultice
JPS5610887A (en) * 1979-07-09 1981-02-03 Babcock Hitachi Kk Handrall structure of joint portion of duct
JPS5855417A (ja) * 1981-09-27 1983-04-01 Nitto Electric Ind Co Ltd 医薬組成物
EP0158090B1 (de) * 1984-03-07 1990-08-29 Roshdy Dr. Ismail Mittel zur Behandlung und zum Schutz der Haut
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4886783A (en) * 1986-01-31 1989-12-12 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4917896A (en) * 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
GB8630721D0 (en) * 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
US4847069A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4869897A (en) * 1987-10-22 1989-09-26 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid
JP2663136B2 (ja) * 1988-05-02 1997-10-15 有限会社野々川商事 美白化粧料
ATE101511T1 (de) * 1988-08-02 1994-03-15 Ciba Geigy Ag Mehrschichtiges pflaster.
WO1992016236A1 (en) * 1991-03-19 1992-10-01 Rajadhyaksha Vithal J Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition

Also Published As

Publication number Publication date
AU2726692A (en) 1993-04-29
DE69226491T2 (de) 1999-01-14
EP0539215B1 (en) 1998-08-05
NZ244862A (en) 1995-07-26
AU658681B2 (en) 1995-04-27
DE69226491D1 (de) 1998-09-10
EP0539215A1 (en) 1993-04-28
ATE169228T1 (de) 1998-08-15
CA2081269C (en) 2002-03-05
US6017520A (en) 2000-01-25
KR930007445A (ko) 1993-05-20
JPH06128176A (ja) 1994-05-10
CA2081269A1 (en) 1993-04-24
ES2119800T3 (es) 1998-10-16
JP2671248B2 (ja) 1997-10-29

Similar Documents

Publication Publication Date Title
DK0539215T3 (da) Forøgelse af penetrationen af topisk anvendelige formuleringer
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
ATE137665T1 (de) Kosmetisches mittel
ATE104845T1 (de) Tocopherolsorbat und entzuendungshemmende wirkstoffe enthaltende lichtschutzmittel.
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
ATE55247T1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
FI88459B (fi) Foerfarande foer framstaellning av en foer intranasal applikation laemplig steroidkomposition
DE69315927D1 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
DE69005398D1 (de) Topisch kosmetisch anzuwendende depolymerisierte Nukleinsäuren enthaltende Arzneizubereitungen.
DE69222318D1 (de) Hautpflegemittel
ATE29382T1 (de) Arzneimittel zur behandlung von haarausfall.
IT7949034A0 (it) Perfezionamento nelle composizioni emollienti per emulsioni creme paste cosmetiche e simili
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
ATE88628T1 (de) Zusammensetzung zur aeusserlichen verabreichung, die eine ethoxylat-verbindung enthaelt.
ES545063A0 (es) Producto antiseptico
ATE46083T1 (de) Arzneimittel zur topischen anwendung.
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung